
© 2025 wallstreetONLINE TV
Realtime | Geld | Brief | Zeit |
---|---|---|---|
102,38 | 102,50 | 12.06. | |
102,20 | 102,60 | 12.06. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
05:14 | Unpacking AMD's MI350: Powered by TSMC's N3P, with Samsung/ Micron as Dual HBM3E Suppliers | ||
03:22 | AMD Confirms Samsung HBM3E for New AI Accelerator MI350X | ||
Do | AMD Unveils Its Latest Chips, With ChatGPT Maker OpenAI Among Its Customers | ||
Do | AMD enthüllt neue KI-Hardware und Software auf der Advancing AI 2025 | SANTA CLARA, Kalifornien (IT-Times) - Der US-amerikanische Prozessor-Designer AMD präsentiert eine Vision für ein offenes KI-Ökosystem und stellt neue Chips, Software und Systeme vor. Advanced Micro... ► Artikel lesen | |
Do | AMD unveils AI server as OpenAI taps its newest chips |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
03:36 | Novo Nordisk To Start Phase 3 Trial Of Amycretin For Weight Loss In Early 2026 | WASHINGTON (dpa-AFX) - Novo Nordisk (NVO) announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies. This... ► Artikel lesen | |
00:31 | Why Novo Nordisk Stock Pumped Higher on Thursday | ||
Do | Novo Nordisk plant Spättests für Abnehm-Medikament Amycretin | ||
Do | Novo Nordisk plans late-stage trials for weight-loss drug amycretin | ||
Do | Novo Nordisk to launch late-stage program to test novel obesity candidate |
Unternehmen / Aktien | Kurs | % |
---|---|---|
ADVANCED MICRO DEVICES INC | 102,36 | 0,00 % |
NOVO NORDISK A/S | 70,23 | +0,14 % |